PepsiCo (NASDAQ:PEP) said on Tuesday (October 2) that it will evaluate the cannabis industry in the wake of beverage companies gaining entries into the booming space.

Hugh Johnston, chief financial officer (CFO) of the beverage company, said no deal is currently in place but plans to study the sector during a televised interview.


“I think we’ll look at it critically, but I’m not prepared to share any plans that we may have in the space right now,” he said.

PepsiCo would join its beverage counterpart, The Coca-Cola Company (NYSE:KO), in showing interest for a cannabis play. A report from BNN Bloomberg showed alcohol producer Diageo (NYSE:DEO) was also eyeing a partnership in the cannabis space.

“Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time,” Coca-Cola said at the height of a report indicating it would partner with Aurora Cannabis (TSX:ACB) in some form.

Other beverage companies have already gained direct exposure through partnerships with cannabis producers. Last November alcohol producer Constellation Brands (NYSE:STZ) formed an investment partnership with Canopy Growth (NYSE:CGC,TSX:WEED).

This relationship was renewed in August when Constellation made a second investment worth C$5 billion in Canopy’s business.

The cannabis industry gained a different type of deal when Molson Coors (NYSE:TAP) formed a joint venture with HEXO (TSX:HEXO).

“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space,” Rob Sands, CEO of Constellation Brands, said in a press release.

At the core of these relationships is the intention to bring forward a new type of product into the legal market: infused cannabis beverages. The bet these companies are making is for a drink that can offer a buzz to consumers with no calories.

Infused beverages haven’t caught the eye of just major producers; many small-to-mid cap cannabis companies have also announced intentions to develop some form of cannabis-infused beverage.

These beverages have been available to consumers in refined cannabis black markets like Colorado and California, but one thing companies are working on as validation is the refinement behind these new drinks.

“Some people are impatient looking for that effect so they drink too much and when it finally hits, they are out of it for a long, long time, Kris Dahl, VP of corporate development with Sproutly (CSE:SPR) told the Investing News Network (INN).

Sproutly, which was added to the Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR) in September, will use its technology to develop and sell cannabis-infused water.

“Ours are less than five minutes onset and in less than 90 minutes it’s fully out of your system,” Dahl explained.

Despite recreational legalization of cannabis arriving in Canada on October 17, infused beverages won’t become immediately available to legal consumers.

Health Canada, the government agency tasked with regulating the drug, has indicated legalization for infused products and cannabis edibles will be arriving approximately a year after legalization.

Investor takeaway

The confirmation from PepsiCo’s potential interest in cannabis adds another major player into the mix for a possible entry. This move has brought legitimacy to the cannabis play and a wider set of investors to take notice.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less